KATHERINE LANGLAIS: Open Payments
NPI 1689299687 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,171 in 61 payments from 9 companies in 2025. Trend: 2023 $576 · 2024 $1,839 · 2025 $2,171
Food & beverage: $2,126Education: $45
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 16 | $815 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $380 |
| ANI Pharmaceuticals, Inc. | 9 | $298 |
| Astellas Pharma US Inc | 6 | $296 |
| Actelion Pharmaceuticals US, Inc. | 16 | $210 |
| Merck Sharp & Dohme LLC | 3 | $96 |
| Mallinckrodt Hospital Products Inc. | 1 | $28 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: PURIFIED CORTROPHIN GEL, Cresemba, OFEV, UPTRAVI, Remodulin, Orenitram, STEEN SOLUTION, WINREVAIR.
Industry payments across FL — which companies pay providers there.
